Navigation Links
Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform

SUNNYVALE, Calif., June 22 /PRNewswire/ -- Xoft, makers of Electronic Brachytherapy systems based upon miniaturized X-ray tube technology, today announced the integration of its Axxent® Electronic Brachytherapy System at the Pink Lotus Breast Center, a state of the art, fully comprehensive breast center exclusively dedicated to the prevention, screening, diagnosis and treatment of breast cancer. The Pink Lotus Breast Center is the first comprehensive breast center in the nation to integrate Electronic Brachytherapy.

"As a leader in comprehensive breast cancer care, we are very excited to add electronic brachytherapy to our slate of life-saving treatment methods," said Dr. Kristi Funk, breast surgeon and founder of the Pink Lotus Breast Center. "The ability to utilize isotope-free, electronic treatment that effectively targets the cancer site while minimizing radiation exposure to healthy tissues is something we are proud to make available to our patients."

Available for treatment of early stage breast cancer and other types of cancer, the Axxent® Electronic Brachytherapy system, eBx™, is FDA-cleared for IORT and surface indications, which allows the system to be used on any external or internal surface of the body where radiation therapy is indicated. In its treatment of early stage breast cancer, the Axxent system provides the opportunity to reduce the therapy time required from seven weeks (for external radiation therapy) down to five days or a single dose for IORT. Utilizing a miniaturized X-ray source instead of a radioactive isotope, the Axxent system can be used to deliver radiation in minimally shielded therapeutic settings allowing the radiation oncologist and other medical personnel to be present during treatment delivery which minimizes patient anxiety.

"The Pink Lotus Breast Center is an innovative organization dedicated to improving the impact and quality of patient care by combining a large variety of medical approaches with the latest technologies available," said Michael Klein, CEO and President of Xoft. "We are excited to partner with the Pink Lotus Breast Center to make electronic brachytherapy available at a time when clinical studies continue to reinforce the clinical value of this treatment for breast cancer."

About Xoft

Xoft develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. The Axxent® treatment platform provides a therapeutic dose of radiation directly to the region at risk with minimal radiation exposure to surrounding healthy tissue and without the logistics and costs associated with using radioactive isotopes.  Available for treatment of early stage breast cancer, skin cancer and endometrial cancer, the Axxent System is also cleared for use in the treatment of other cancers or conditions where radiation therapy is indicated. For information, visit

About Pink Lotus Breast Center

The Pink Lotus Breast Center is a comprehensive and integrative breast center exclusively dedicated to the prevention, screening, diagnosis and treatment of breast cancer. The organization's state of the art centers are run by women, for the benefit of women. At the Pink Lotus Breast Center, women enjoy the unique experience of holistic care linked seamlessly to the latest digital mammography technology and state-of-the-art surgery, all in one single location. The company's mission conveys one clear purpose: to offer the most comprehensive and integrative breast care available today in a warm environment that provides all women with security and confidence when they need it most. For more information, visit or Pink Lotus Breast Center is a trademark of Pink Lotus Medical Holdings, LLC.

Axxent is a registered trademark and eBx is a trademark of Xoft, Inc.

SOURCE Xoft, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
2. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
3. Lotus Pharmaceuticals to Exhibit at the 63rd PHARMCHINA
4. Lotus Pharmaceuticals Reports Groundbreaking Ceremony
5. Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores
6. Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
7. Lotus Pharmaceuticals, Inc. Reports Third-Quarter 2009 Results
8. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
9. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
10. Society of Nuclear Medicine Releases New Guidelines for Breast-Specific Gamma Imaging
11. TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System
Post Your Comments:
(Date:11/27/2015)... PHILADELPHIA , Nov. 27, 2015  Lannett ... that it has completed the acquisition of Kremers ... pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. ... --> Lannett has acquired KU from UCB ... to certain adjustments, including a customary working capital ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> Juntendo University Hospital ... weighting of MRI for patients with Multiple Sclerosis (MS) ... with SyntheticMR in order to use SyMRI in clinical research ... generate multiple contrast images from a single scan and adjust ... it possible to both fine tune images and recreate additional ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions ... SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of ... SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates ...
(Date:11/27/2015)... MINNEAPOLIS, Minn. (PRWEB) , ... November 27, 2015 ... ... you start failing. Secura Consultants has prided itself for not only fulfilling the ... best income protection solutions at an affordable price and providing top-tier customer service. ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
(Date:11/27/2015)... Rosa, CA (PRWEB) , ... November 27, 2015 , ... ... Northern California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at ... meeting. They observed that both STEMI and Sepsis conditions present in similar ways and ...
Breaking Medicine News(10 mins):